sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID

Lisa Hurler, Federica Mescia, Laura Bergamaschi, Erika Kajdácsi, György Sinkovits, László Cervenak, Zoltán Prohászka, Paul A. Lyons, Erik J.M. Toonen

Open source

DOI
10.1016/j.isci.2024.110162
Published
2024-07
Container
iScience
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.isci.2024.110162,
  title = {sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID},
  author = {Lisa Hurler and Federica Mescia and Laura Bergamaschi and Erika Kajdácsi and György Sinkovits and László Cervenak and Zoltán Prohászka and Paul A. Lyons and Erik J.M. Toonen},
  year = {2024},
  journal = {iScience},
  doi = {10.1016/j.isci.2024.110162},
  url = {https://doi.org/10.1016/j.isci.2024.110162}
}

RIS

TY  - JOUR
TI  - sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID
AU  - Lisa Hurler
AU  - Federica Mescia
AU  - Laura Bergamaschi
AU  - Erika Kajdácsi
AU  - György Sinkovits
AU  - László Cervenak
AU  - Zoltán Prohászka
AU  - Paul A. Lyons
AU  - Erik J.M. Toonen
PY  - 2024
JO  - iScience
DO  - 10.1016/j.isci.2024.110162
UR  - https://doi.org/10.1016/j.isci.2024.110162
ER  - 

APA

Hurler, L., Mescia, F., Bergamaschi, L., Kajdácsi, E., Sinkovits, G., Cervenak, L., Prohászka, Z., Lyons, P. A., & Toonen, E. J. (2024). sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID. iScience. https://doi.org/10.1016/j.isci.2024.110162

Source records